ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CYPH vs AVIR // RETURN ON INVESTED CAPITAL (ROIC)

Cypherpunk Technologies Inc. (NASDAQ) VS. Atea Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: CYPH 3 — AVIR 0
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CYPH
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYPH VS. AVIR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CYPH AVIR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -23.30% -35.00% +11.70 CYPH /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -12.31% — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.0 32.4 +18.57 CYPH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 66.3x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $356.7M $345.7M $11.0M CYPH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CYPH REV AVIR REV CYPH GROSS % AVIR GROSS % CYPH FCF AVIR FCF
FY 2025 $0 $0 — — -$43.9M -$132.0M
FY 2024 $0 $0 — — -$60.3M -$135.5M
FY 2023 $0 $0 — — -$43.8M -$85.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYPH // BETA —
AVIR // BETA —